Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT06176469

Renal Colic and Urolithiasis in Poland

The aim of this study is to analyze the prevalence, effect on quality of life, and treatment-related behaviors for renal colic and urolithiasis in a population-representative sample of Poles. We will be using an Internet interview format for renal colic and urolithiasis evaluation. The study will include respondents representative for age and place of residence with adequate proportions of respondents from urban and rural areas.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Urology, Jagiellonian University

Krakow, Poland

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • consent to participate

Exclusion criteria

  • lack of consent to participate

Treatment and study plan

No intervention

Other

No intervention

Primary outcomes

  1. Prevalence of renal colic and urolithiasis in Poland

    Time frame: December 2023 - December 2024

    Prevalence of renal colic and urolithiasis in Poland

Sponsors and collaborators

Lead sponsor

Mikolaj Przydacz

Other

Registry information

Official study title

Population-level Prevalence, Effect on Quality of Life, and Treatment Behavior for Renal Colic and Urolithiasis in Poland

Acronym: POLSTONE

Important dates

Study start
2023
Primary completion
2024
Study completion
2025
First posted
Dec 19, 2023
Registry last updated
Feb 11, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.